Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

  Last updated 4/1/2010    

The Future of Drug Delivery is Here

At Teikoku Pharma, we see a world without barriers. Where therapeutic challenges are merely stepping stones to new solutions. Where creative thinking creates new opportunities — for pharmaceutical companies, physicians and patients. Where new territories in drug development and drug delivery are being charted every day.

As an international specialty pharmaceutical company and a world leader in the research, development and manufacture of pharmaceutical transdermal products, Teikoku Pharma is transforming medicine through innovative solutions.


December 28, 2015

Teikoku Pharma USA, Inc. Announces FDA
Approval of Docetaxel Injection, Non-Alcohol Formula

San Jose, CA, October 15, 2015

Teikoku Pharma USA and Eagle Pharmaceuticals
Enter into License Agreement for Docetaxel, Non-Alcohol Formula.

March 24, 2015

Teikoku Pharma USA Announces New Drug
Application to The U.S. Food and Drug
Administration for Docetaxel Injection
Concentrate, Non-Alcohol Formula

Copyright © 2010 Teikoku Pharma USA, Inc. All Rights Reserved.